Pure Global

ZYBIO Creatine Kinase MB Isoenzyme (CK-MB) Kit (Immunoinhibition Method) - Indonesia BPOM Medical Device Registration

ZYBIO Creatine Kinase MB Isoenzyme (CK-MB) Kit (Immunoinhibition Method) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101323559. The device is manufactured by ZYBIO INC. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. ZYBIO MEDICAL INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
ZYBIO Creatine Kinase MB Isoenzyme (CK-MB) Kit (Immunoinhibition Method)
Analysis ID: AKL 20101323559

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

ZYBIO INC.

Country of Origin

China

Authorized Representative

PT. ZYBIO MEDICAL INDONESIA

AR Address

Satrio Tower Unit 8, Lantai 14 No. 5 Bok C4, Jl. Prof. Dr, Satrio No. 7, Kel. Setiabudi, Kec. Kuningan Timur, Kota Jakarta Selatan, Prov. DKI Jakarta

Registration Date

Jul 28, 2023

Expiry Date

Jan 30, 2028

Product Type

Clinical Chemistry Test System

Creatine phosphokinase/creatine kinase or isoenzymes test system(kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing